Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,018 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer

NCT04069026

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Greenville Health System Greenville, South Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics | START San Antonio San Antonio, Texas, United States
View all 17 locations
View Trial Details
Completed

BMS-986012 in Relapsed/Refractory SCLC

NCT02247349

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Local Institution - 0004 New York, United States
  • Local Institution - 0001 Durham, North Carolina, United States
  • Local Institution - 0021 Winston-Salem, North Carolina, United States
  • Local Institution - 0020 St Leonards, New South Wales, Australia
View all 16 locations
View Trial Details
Completed

Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)

NCT03976518

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UO Oncologia Polmonare - AOU S. Luigi Gonzaga Orbassano, Torino, Italy
  • UO di Oncologia Medica - Azienda Ospedaliero-Universitaria S. Orsola Malpighi Bologna, Italy
  • Dipartimento di Oncologia Medica - Azienda Ospedaliera S.Croce e Carle Cuneo - Ospedale Carle Cuneo, Italy
  • S.S. di Oncologia Medica toraco-polmonare - Fondazione IRCCS - Istituto Nazionale Tumori Milan, Italy
View Trial Details
Completed

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

NCT05005273

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0080 Tucson, Arizona, United States
  • Local Institution - 0051 Fountain Valley, California, United States
  • Local Institution - 0070 Fort Myers, Florida, United States
  • Local Institution - 0073 Gainesville, Florida, United States
View all 71 locations
View Trial Details
Completed

Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil

NCT04948411

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Núcleo de Oncologia da Bahia S.A Salvador, Estado de Bahia, Brazil
  • Instituto Mário Penna Belo Horizonte, Minas Gerais, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
  • Sociedade Beneficente de Senhoras Hospital Sírio-Libanês São Paulo, Brazil
View Trial Details
Completed

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

NCT04808050

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Sydney, New South Wales, Australia
  • Research Site Brisbane, Queensland, Australia
  • Research Site Perth, Western Australia, Australia
  • Research Site Alexandria, Egypt
View all 25 locations
View Trial Details

Related conditions